Hylan T R, Dunn R L, Tepner R G, Meurgey F
Fli Lilly and Company, Indianapolis, Indiana 46285, USA.
Int Clin Psychopharmacol. 1998 Nov;13(6):235-43. doi: 10.1097/00004850-199811000-00001.
An important determinant for achieving efficacy results in clinical practice comparable to those demonstrated in clinical trials is whether or not patients take their medication as prescribed. Recent studies have shown that 30-60% of patients do not take their medications as prescribed. Gaps between antidepressant prescriptions raise questions about the possibility of periods of nonadherence to medication in clinical practice. The purpose of conducting this study was to assess the likelihood of experiencing a gap of > 15 days between antidepressant prescriptions for patients with a depression-related diagnosis and to assess whether this likelihood varied across different antidepressants with tricyclic antidepressants and selective serotonin reuptake inhibitors. Episodes of antidepressant treatment were constructed using the Doctors' Independent Network general practitioner medical records database. For all antidepressant agents considered, approximately 50% of patients had a gap between prescriptions and 15-25% of patients had a gap of > 15 days between prescriptions. A significant proportion of patients in a general practitioner setting in the UK have gaps recorded of > 15 days between antidepressant prescriptions. Gaps between prescriptions raise the question of whether patients may be at risk for clinical consequences associated with nonadherence to therapy, such as reduced effectiveness or treatment interruption symptomatology.
在临床实践中取得与临床试验中所证明的疗效相当的结果的一个重要决定因素是患者是否按规定服药。最近的研究表明,30%至60%的患者未按规定服药。抗抑郁药处方之间的间隔引发了关于临床实践中存在未坚持服药期的可能性的疑问。开展这项研究的目的是评估患有抑郁症相关诊断的患者抗抑郁药处方之间间隔超过15天的可能性,并评估这种可能性在三环类抗抑郁药和选择性5-羟色胺再摄取抑制剂等不同抗抑郁药之间是否存在差异。使用医生独立网络全科医生医疗记录数据库构建抗抑郁治疗疗程。对于所有考虑的抗抑郁药,约50%的患者处方之间存在间隔,15%至25%的患者处方之间间隔超过15天。在英国全科医生诊疗环境中,相当一部分患者的抗抑郁药处方之间记录的间隔超过15天。处方之间的间隔引发了一个问题,即患者是否可能面临与不坚持治疗相关的临床后果风险,如疗效降低或治疗中断症状。